Pharmaceuticals, Biotechnology and Life Sciences
CSL Behring AG, a wholly-owned subsidiary of global biotechnology leader CSL Limited has announced the definitive notice of the Interim Result of its public tender offer to acquire all publicly held shares of Vifor Pharma Ltd. for USD 179.25 per share as indicated in the offer prospectus of 18 January 2022.
Valneva SE has announced successful completion of the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553.
Evaxion Biotech has now finalized recruitment for Phase 1/2a clinical trial of EVX-02 in adjuvant melanoma patients.
In this newly created role reporting to the CEO, Dr. Yver will be accountable for the company’s overall development strategy, including scientific, clinical and regulatory matters, and will continue to provide support to research and clinical development teams.
-KONFIDENT to Evaluate KVD900 As First Oral On-Demand Therapy for HAE- -KONFIDENT Designed to Support Broad Label for Treatment of…
Some pharmaceutical companies are donating money to support people in Ukraine and are condemning the war and violence in Ukraine.…
Abbott stands with the international community condemning the war and the violence in Ukraine against its people, and calls for peace.
The Board of Ovoca Bio, an international biopharmaceutical company focusing on women’s health, has issued a statement in response to events in Ukraine and Russia.
Tollys has entered into a sponsored research agreement with Gustave Roussy.
The U.S. Food and Drug Administration had approved the expanded use of Opdivo, BMS’s cancer drug for patients with an aggressive form of lung cancer.